UPEXI INC (UPXI)
US39959A1060 - Common Stock
UPXI gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 36 industry peers in the Personal Care Products industry. UPXI has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, UPXI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
UPXI had negative earnings in the past year.
In the past year UPXI has reported a negative cash flow from operations.
In the past 5 years UPXI reported 4 times negative net income.
In multiple years UPXI reported negative operating cash flow during the last 5 years.
1.2 Ratios
UPXI has a worse Return On Assets (-43.59%) than 82.86% of its industry peers.
UPXI's Return On Equity of -111.66% is on the low side compared to the rest of the industry. UPXI is outperformed by 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -43.59% | ||
| ROE | -111.66% | ||
| ROIC | N/A |
ROA(3y)-6.7%
ROA(5y)-22.4%
ROE(3y)-17.75%
ROE(5y)-480.96%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 31.53%, UPXI is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
UPXI's Gross Margin has improved in the last couple of years.
UPXI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.25%
GM growth 5YN/A
2. Health
2.1 Basic Checks
UPXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, UPXI has more shares outstanding
UPXI has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.47, we must say that UPXI is in the distress zone and has some risk of bankruptcy.
UPXI's Altman-Z score of 0.47 is on the low side compared to the rest of the industry. UPXI is outperformed by 77.14% of its industry peers.
A Debt/Equity ratio of 0.60 indicates that UPXI is somewhat dependend on debt financing.
UPXI has a worse Debt to Equity ratio (0.60) than 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.47 |
ROIC/WACCN/A
WACC10.28%
2.3 Liquidity
A Current Ratio of 0.70 indicates that UPXI may have some problems paying its short term obligations.
UPXI has a worse Current ratio (0.70) than 94.29% of its industry peers.
UPXI has a Quick Ratio of 0.70. This is a bad value and indicates that UPXI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.33, UPXI is not doing good in the industry: 94.29% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.33 |
3. Growth
3.1 Past
The earnings per share for UPXI have decreased strongly by -426.36% in the last year.
Looking at the last year, UPXI shows a very strong growth in Revenue. The Revenue has grown by 44.18%.
Measured over the past years, UPXI shows a very strong growth in Revenue. The Revenue has been growing by 121.64% on average per year.
EPS 1Y (TTM)-426.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-79.74%
Revenue 1Y (TTM)44.18%
Revenue growth 3Y121.64%
Revenue growth 5YN/A
Sales Q2Q%-40.36%
3.2 Future
UPXI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -30.38% yearly.
Based on estimates for the next years, UPXI will show a small growth in Revenue. The Revenue will grow by 7.17% on average per year.
EPS Next Y-145%
EPS Next 2Y-30.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.26%
Revenue Next 2Y7.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for UPXI. In the last year negative earnings were reported.
Also next year UPXI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as UPXI's earnings are expected to decrease with -30.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-30.38%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for UPXI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
UPEXI INC
NASDAQ:UPXI (11/21/2024, 8:00:01 PM)
After market: 4.9 -0.31 (-5.95%)5.21
+0.81 (+18.41%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.42M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -43.59% | ||
| ROE | -111.66% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.53% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.33 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-426.36%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-145%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)44.18%
Revenue growth 3Y121.64%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y